COMMUNIQUÉS West-GlobeNewswire

Globus Medical Launches ExcelsiusHub™ Navigation System

22/11/2024 - 22:30

AUDUBON, Pa., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ExcelsiusHub™ navigation system. ExcelsiusHub [...]

Anika To Participate in December 2024 Investor Conferences

22/11/2024 - 22:16

BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will participate [...]

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

22/11/2024 - 22:05

BRISBANE, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on November 18, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards [...]

Organogenesis Expands Manufacturing Capacity to Support Future Growth

22/11/2024 - 22:05

CANTON, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]

Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares

22/11/2024 - 17:00

Company announcement no. 11 - 24 22 November 2024 Reporting of transactions made by persons discharging managerial responsibilities, and persons closely associated with them, in NTG's shares In accordance with section [...]

RadNet Secures Commitments to Amend its Credit Facility, Resulting in 0.25% Reduction in Interest Rates

22/11/2024 - 17:00

LOS ANGELES, Nov. 22, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that it has [...]

Combination of Eflornithine and Lomustine Demonstrates Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma, IDH Mutant Grade 3

22/11/2024 - 17:00

– OS and PFS Study endpoints met in large subgroup of patients with recurrent astrocytoma, IDH mutant grade 3 as defined by the 2021 WHO CNS Tumor Classification in Orbus Therapeutics’ Phase 3 STELLAR study – – [...]

Raw Garden Unveils Unprecedented “Thankful For You” Deals for Green Wednesday, Black Friday, and Cyber Monday

22/11/2024 - 15:29

California’s Premier Cannabis Brand Offers Its Biggest Discounts Ever: 30%+ Off All Products SANTA BARBARA COUNTY, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- This holiday season, Raw Garden , California’s most trusted [...]

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

22/11/2024 - 15:15

THE WOODLANDS, TX, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today [...]

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note

22/11/2024 - 15:10

WOBURN, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization of photodynamic [...]

Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities

22/11/2024 - 15:00

November 22, 2024 Vendor-agnostic, multi-modality Radiology Operations Command Center (ROCC) connects technologists, radiologists, and operations teams in real time New FDA 510(k) cleared remote scanning and protocol [...]

Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement

22/11/2024 - 14:36

NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today [...]

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

22/11/2024 - 14:30

SeaStar Medical urges stockholders to vote FOR all proxy proposals prior to the Special Meeting of Stockholders to be held November 26, 2024 DENVER, Nov. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation [...]

Result of General Meeting

22/11/2024 - 14:30

November 22, 2024 Biodexa Pharmaceuticals PLC (“ Biodexa ” or the “ Company ”) Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage biopharmaceutical [...]

BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering

22/11/2024 - 14:16

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines [...]

Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)

22/11/2024 - 14:00

DURHAM, N.C., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today [...]

Aptose Biosciences Inc. Announces Pricing of $8 Million Public Offering

22/11/2024 - 14:00

SAN DIEGO and TORONTO, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]

EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting

22/11/2024 - 14:00

Early feasibility work demonstrates Focal One system’s ability to generate histotripsy lesions ex vivo LYON, France, November 22, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, [...]

Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA

22/11/2024 - 13:32

Implementing Strategic Restructuring to Eliminate Commercial Organization and Rationalize Operations Across All Functions Prioritizing Strong R&D Pipeline Including Ongoing Studies in DPNP, HCM and Obesity Efforts [...]